G5044

GR 32191B

≥98% (HPLC), solid

• Sinónimos: (4Z)-7-[(1R,2R,3S,5S)-5-([1,1′-Biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoic acid hydrochloride
• Fórmula empírica (notación de Hill): C₃₀H₄₀NO₄Cl
• Número de CAS: 87248-13-3
• Peso molecular: 514.10
• MDL number: MFCD04113055
• UNSPSC Code: 12352200
• PubChem Substance ID: 329799744
• NACRES: NA.77

Propiedades

• assay: ≥98% (HPLC)
• form: solid
• color: off-white
• mp: 127-128 °C
• solubility: H₂O: ~16 mg/mL
• originator: GlaxoSmithKline
• shipped in: wet ice
• storage temp.: −20°C
• SMILES string: Cl.O[C@H]1C[C@H](OCc2ccc(cc2)-c3ccccc3)[C@H](CC\C=C/CCC(O)=O)[C@H]1N4CCCCC4
• InChI: 1S/C30H39NO4.ClH/c32-27-21-28(35-22-23-15-17-25(18-16-23)24-11-5-3-6-12-24)26(13-7-1-2-8-14-29(33)34)30(27)31-19-9-4-10-20-31;/h1-3,5-6,11-12,15-18,26-28,30,32H,4,7-10,13-14,19-22H2,(H,33,34);1H/b2-1-;/t26-,27-,28-,30+;/m0./s1
• InChI key: ZYOBZRTZRQKKNC-UGNABIHOSA-N

Descripción

Biochem/physiol Actions

Selective TP prostanoid receptor antagonist. Inhibits U-46619-induced contraction of guinea pig trachea with IC₅₀=1.8 nM.

Features and Benefits

This compound is featured on the Prostanoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Legal Information

Manufactured and sold under agreement from Glaxo­Smith­Kline

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)